title: Vesicular Sézary syndrome with bullous lesions on the feet.
authors.forename: Luis
authors.initials: L
authors.lastname: Dehesa
authors.forename: Jesús
authors.initials: J
authors.lastname: Bastida
authors.forename: Rafael
authors.initials: R
authors.lastname: Camacho-Galán
authors.forename: Conrado
authors.initials: C
authors.lastname: Campos-Adsuar
authors.forename: Javier
authors.initials: J
authors.lastname: Gómez-Duaso
authors.forename: Jaime
authors.initials: J
authors.lastname: Vilar-Alejo
mesh_terms: D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols; D001768:Blister / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D005260:Female; D005533:Foot Dermatoses / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D011241:Prednisone / Q000627:therapeutic use; D012751:Sezary Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone